Dolsten Mikael

Dolsten Mikael is listed in filings as Director at Agilent Technologies Inc. This profile follows SEC Form 4 activity through Jun 2, 2026, including sale activity. Recent filings connect the profile to Agilent Technologies Inc (A), Apellis Pharmaceuticals, Inc. (APLS), Rocket Pharmaceuticals, Inc. (RCKT), and Pfizer Inc (Ritu 1985 Trust) (PFE). The current snapshot covers public activity from Sep 11, 2024 to Jun 2, 2026. Reported amounts are shown as $216.7K to $57.2K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.